691 in Vitro Evaluation of Naltrexone HCl 1% Topical Cream in Xematop for Psoriasis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.767
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

(434) Considerations for Perioperative Contrave (Naltrexone HCl/bupropion HCl) Administration

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2016English

Topical Tacrolimus for Psoriasis

The Open Allergy Journal
2009English

BUCCOADHESIVE TABLETS FOR DELIVERY OF VERAPAMIL HCl: DESIGN, IN-VITRO ANALYSIS AND IN-VIVO EVALUATION

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2012English

Formulation of Meloxicam Gel for Topical Application: In Vitro and in Vivo Evaluation

Acta Pharmaceutica
MedicinePharmacologyPharmaceutical Science
2010English

Low-Dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis

Cureus
2019English

Topical Application of Naltrexone Facilitates Reepithelialization of the Cornea in Diabetic Rabbits

Brain Research Bulletin
Neuroscience
2010English

Solasodine Glycosides From the Eggplant in a Topical Cream Psorend<sup>BEC</Sup> Are Effective Against Psoriasis

International Journal of Clinical Medicine
2019English

A Randomized Phase 3b/4 Study to Evaluate Concomitant Use of Topical Ivermectin 1% Cream and Doxycycline 40 Mg Modified-Release Capsules Versus Topical Ivermectin 1% Cream and Placebo in the Treatment of Severe Rosacea

Journal of the American Academy of Dermatology
Dermatology
2020English

Formulation and in Vitro Evaluation of Carbopol 934-Based Modified Clotrimazole Gel for Topical Application

Anais da Academia Brasileira de Ciencias
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy